庆祝神经病理学对阿尔茨海默氏病研究中心的贡献
D Luke Fischer1, Lea T Grinberg2,3,4, Jared T Ahrendsen5
1Memory and Aging Center, Department of Neurology, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, California, USA.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|October 14, 2025
概括
神经病理学研究,由国家老龄研究所支持.
科学领域:
- 神经科学是一个神经科学.
- 病理学 病理学 病理学
- 生物医学研究生物医学研究
背景情况:
- 美国国家老龄化研究所 (NIA) 在过去40年里,在阿尔茨海默氏症 (AD) 和相关痴呆症 (ADRD) 研究方面取得了重大进展.
- 神经病理学是理解神经退行症的基础,建立了诸如蛋白质病变和选择性脆弱性等关键原则.
研究的目的:
- 为了庆祝NIA资助的阿尔茨海默氏病研究中心 (ADRC) 成立40周年.
- 突出神经病理学在促进ADRD研究,诊断和治疗开发方面的关键作用.
主要方法:
- 审查神经病理学研究及其对ADRD理解的贡献.
- 强调数字病理学,遗传学和病理学的整合.
主要成果:
- 神经病理学已经阐明了神经退行性疾病的核心原则,包括蛋白质病变,选择性脆弱性和刻板印象传播.
- 神经病理学研究推动了生物标志物的发展,改善了临床病理相关性,并为AD提供了疾病修饰疗法.
- 数字病理学的进步和集成的"omics"有望改进诊断和精准医学方法.
结论:
- 神经病理学仍然是ADRD研究基础设施中不可或缺的组成部分,桥梁基础科学和临床科学.
- 持续的研究和解决神经病理学的后勤挑战对于推进ADRD诊断和治疗至关重要.
- 神经病理学中各种方法的整合正在为神经退行性疾病的个性化医学铺平道路.
相关概念视频
01:26Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
01:22Alzheimer's Disease: Treatment
822
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
822